Document is current
Any future updates will be listed below
-
Authors
Gattepaille, Lucie M.
Hedfors Vidlin, Sara
Bergvall, Tomas
Pierce, Carrie E.
Ellenius, Johan
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative (115632)
- License Information
-
More Information
Article History
First Online: 14 May 2020
Compliance with Ethical Standards
:
: The research leading to these results was conducted as part of the WEB-RADR consortium (), which is a public–private partnership coordinated by the Medicines and Healthcare products Regulatory Agency. The WEB-RADR project has received support from the Innovative Medicine Initiative Joint Undertaking () under Grant Agreement No. 115632, resources of which are composed of financial contributions from the European Union’s Seventh Framework Programme (FP7/2007–2013) and the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution.
: Carrie E. Pierce has no conflict of interest directly relevant to the content of this study. Lucie M. Gattepaille, Sara Hedfors Vidlin, Tomas Bergvall and Johan Ellenius are employed by the Uppsala Monitoring Centre, a non-profit foundation that commercializes WHODrug Global, the drug dictionary used in this study.
: Not applicable.
: Not applicable.
: Not applicable.
: The training data, generously provided by the WEB-RADR consortium member Epidemico Inc. (now part of Booz Allen Hamilton), is proprietary and cannot be shared with others. The WEB-RADR reference dataset used for prospective evaluation is publicly available at .
: Code is unavailable.
